aluates Reports

$ 0.0

Automative

Global Oral Antidiabetic Agents Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-33U2707

Global Oral Antidiabetic Agents Market Insights Forecast to 2028

BUY CHAPTERS

Global Oral Antidiabetic Agents Market Insights, Forecast to 2030

Code: QYRE-Auto-33U2707

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

Sanofi

Roche

TEVA

Astrazeneca plc

Wockhardt UK

Merck

Pfizer Inc

Cipla Ltd

Novo Nordisk

Oral Antidiabetic Agents Market

Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.

Market Analysis and Insights: Global Oral Antidiabetic Agents Market

The global Oral Antidiabetic Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Oral Antidiabetic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Oral Antidiabetic Agents is widely used in various fields, such as Home Use, Medical Institutions and Others,, etc. Home Use provides greatest supports to the Oral Antidiabetic Agents industry development. In 2023, global % revenue of Oral Antidiabetic Agents went into Home Use filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Oral Antidiabetic Agents market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oral Antidiabetic Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oral Antidiabetic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Antidiabetic Agents revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Antidiabetic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oral Antidiabetic Agents revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Oral Antidiabetic Agents Market Report

Report Metric	Details
Report Name	Oral Antidiabetic Agents Market
Segment by Type	Sulfonylureas Meglitinides Biguanides Thiazolidinediones Alpha-glucosidase Inhibitors
Segment by Application	Home Use Medical Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck, Pfizer, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oral Antidiabetic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Antidiabetic Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Oral Antidiabetic Agents Market report?

Ans: The main players in the Oral Antidiabetic Agents Market are Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck, Pfizer, Cipla

What are the Application segmentation covered in the Oral Antidiabetic Agents Market report?

Ans: The Applications covered in the Oral Antidiabetic Agents Market report are Home Use, Medical Institutions, Others

What are the Type segmentation covered in the Oral Antidiabetic Agents Market report?

Ans: The Types covered in the Oral Antidiabetic Agents Market report are Sulfonylureas, Meglitinides, Biguanides, Thiazolidinediones, Alpha-glucosidase Inhibitors

Recommended Reports

Oral Antidiabetics

Diabetes Therapies

Related Oral Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Sulfonylureas

1.2.3 Meglitinides

1.2.4 Biguanides

1.2.5 Thiazolidinediones

1.2.6 Alpha-glucosidase Inhibitors

1.3 Market by Application

1.3.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Home Use

1.3.3 Medical Institutions

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Antidiabetic Agents Market Perspective (2019-2030)

2.2 Global Oral Antidiabetic Agents Growth Trends by Region

2.2.1 Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oral Antidiabetic Agents Historic Market Size by Region (2019-2024)

2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030)

2.3 Oral Antidiabetic Agents Market Dynamics

2.3.1 Oral Antidiabetic Agents Industry Trends

2.3.2 Oral Antidiabetic Agents Market Drivers

2.3.3 Oral Antidiabetic Agents Market Challenges

2.3.4 Oral Antidiabetic Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Oral Antidiabetic Agents by Players

3.1.1 Global Oral Antidiabetic Agents Revenue by Players (2019-2024)

3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2019-2024)

3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Oral Antidiabetic Agents, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Oral Antidiabetic Agents Market Concentration Ratio

3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2023

3.5 Global Key Players of Oral Antidiabetic Agents Head office and Area Served

3.6 Global Key Players of Oral Antidiabetic Agents, Product and Application

3.7 Global Key Players of Oral Antidiabetic Agents, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic Agents Breakdown Data by Type

4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2019-2024)

4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030)

5 Oral Antidiabetic Agents Breakdown Data by Application

5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2019-2024)

5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oral Antidiabetic Agents Market Size (2019-2030)

6.2 North America Oral Antidiabetic Agents Market Size by Type

6.2.1 North America Oral Antidiabetic Agents Market Size by Type (2019-2024)

6.2.2 North America Oral Antidiabetic Agents Market Size by Type (2025-2030)

6.2.3 North America Oral Antidiabetic Agents Market Share by Type (2019-2030)

6.3 North America Oral Antidiabetic Agents Market Size by Application

6.3.1 North America Oral Antidiabetic Agents Market Size by Application (2019-2024)

6.3.2 North America Oral Antidiabetic Agents Market Size by Application (2025-2030)

6.3.3 North America Oral Antidiabetic Agents Market Share by Application (2019-2030)

6.4 North America Oral Antidiabetic Agents Market Size by Country

6.4.1 North America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Oral Antidiabetic Agents Market Size by Country (2019-2024)

6.4.3 North America Oral Antidiabetic Agents Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Oral Antidiabetic Agents Market Size (2019-2030)

7.2 Europe Oral Antidiabetic Agents Market Size by Type

7.2.1 Europe Oral Antidiabetic Agents Market Size by Type (2019-2024)

7.2.2 Europe Oral Antidiabetic Agents Market Size by Type (2025-2030)

7.2.3 Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)

7.3 Europe Oral Antidiabetic Agents Market Size by Application

7.3.1 Europe Oral Antidiabetic Agents Market Size by Application (2019-2024)

7.3.2 Europe Oral Antidiabetic Agents Market Size by Application (2025-2030)

7.3.3 Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)

7.4 Europe Oral Antidiabetic Agents Market Size by Country

7.4.1 Europe Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Oral Antidiabetic Agents Market Size by Country (2019-2024)

7.4.3 Europe Oral Antidiabetic Agents Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Oral Antidiabetic Agents Market Size (2019-2030)

8.2 China Oral Antidiabetic Agents Market Size by Type

8.2.1 China Oral Antidiabetic Agents Market Size by Type (2019-2024)

8.2.2 China Oral Antidiabetic Agents Market Size by Type (2025-2030)

8.2.3 China Oral Antidiabetic Agents Market Share by Type (2019-2030)

8.3 China Oral Antidiabetic Agents Market Size by Application

8.3.1 China Oral Antidiabetic Agents Market Size by Application (2019-2024)

8.3.2 China Oral Antidiabetic Agents Market Size by Application (2025-2030)

8.3.3 China Oral Antidiabetic Agents Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Oral Antidiabetic Agents Market Size (2019-2030)

9.2 Asia Oral Antidiabetic Agents Market Size by Type

9.2.1 Asia Oral Antidiabetic Agents Market Size by Type (2019-2024)

9.2.2 Asia Oral Antidiabetic Agents Market Size by Type (2025-2030)

9.2.3 Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)

9.3 Asia Oral Antidiabetic Agents Market Size by Application

9.3.1 Asia Oral Antidiabetic Agents Market Size by Application (2019-2024)

9.3.2 Asia Oral Antidiabetic Agents Market Size by Application (2025-2030)

9.3.3 Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)

9.4 Asia Oral Antidiabetic Agents Market Size by Region

9.4.1 Asia Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Oral Antidiabetic Agents Market Size by Region (2019-2024)

9.4.3 Asia Oral Antidiabetic Agents Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type

10.2.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application

10.3.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country

10.4.1 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Details

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction

11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.1.5 Novo Nordisk Recent Developments

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction

11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.2.5 Eli Lilly Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Oral Antidiabetic Agents Introduction

11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.3.5 Sanofi Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Oral Antidiabetic Agents Introduction

11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.4.5 Roche Recent Developments

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Oral Antidiabetic Agents Introduction

11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.5.5 Teva Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction

11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.6.5 AstraZeneca Recent Developments

11.7 Wockhardt UK

11.7.1 Wockhardt UK Company Details

11.7.2 Wockhardt UK Business Overview

11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction

11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.7.5 Wockhardt UK Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Oral Antidiabetic Agents Introduction

11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Oral Antidiabetic Agents Introduction

11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.9.5 Pfizer Recent Developments

11.10 Cipla

11.10.1 Cipla Company Details

11.10.2 Cipla Business Overview

11.10.3 Cipla Oral Antidiabetic Agents Introduction

11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.10.5 Cipla Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly

Sanofi

Roche

TEVA

Astrazeneca plc

Wockhardt UK

Merck

Pfizer Inc

Cipla Ltd

Novo Nordisk

List of Tables

Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Sulfonylureas

Table 3. Key Players of Meglitinides

Table 4. Key Players of Biguanides

Table 5. Key Players of Thiazolidinediones

Table 6. Key Players of Alpha-glucosidase Inhibitors

Table 7. Global Oral Antidiabetic Agents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Oral Antidiabetic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Oral Antidiabetic Agents Market Share by Region (2019-2024)

Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Oral Antidiabetic Agents Market Share by Region (2025-2030)

Table 13. Oral Antidiabetic Agents Market Trends

Table 14. Oral Antidiabetic Agents Market Drivers

Table 15. Oral Antidiabetic Agents Market Challenges

Table 16. Oral Antidiabetic Agents Market Restraints

Table 17. Global Oral Antidiabetic Agents Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Oral Antidiabetic Agents Revenue Share by Players (2019-2024)

Table 19. Global Top Oral Antidiabetic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)

Table 20. Global Oral Antidiabetic Agents Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Oral Antidiabetic Agents, Headquarters and Area Served

Table 23. Global Key Players of Oral Antidiabetic Agents, Product and Application

Table 24. Global Key Players of Oral Antidiabetic Agents, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2019-2024)

Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2025-2030)

Table 30. Global Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Oral Antidiabetic Agents Revenue Share by Application (2019-2024)

Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Oral Antidiabetic Agents Revenue Share by Application (2025-2030)

Table 34. North America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Oral Antidiabetic Agents Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Oral Antidiabetic Agents Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Oral Antidiabetic Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 66. Novo Nordisk Company Details

Table 67. Novo Nordisk Business Overview

Table 68. Novo Nordisk Oral Antidiabetic Agents Product

Table 69. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 70. Novo Nordisk Recent Developments

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Oral Antidiabetic Agents Product

Table 74. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 75. Eli Lilly Recent Developments

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi Oral Antidiabetic Agents Product

Table 79. Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 80. Sanofi Recent Developments

Table 81. Roche Company Details

Table 82. Roche Business Overview

Table 83. Roche Oral Antidiabetic Agents Product

Table 84. Roche Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 85. Roche Recent Developments

Table 86. Teva Company Details

Table 87. Teva Business Overview

Table 88. Teva Oral Antidiabetic Agents Product

Table 89. Teva Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 90. Teva Recent Developments

Table 91. AstraZeneca Company Details

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca Oral Antidiabetic Agents Product

Table 94. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 95. AstraZeneca Recent Developments

Table 96. Wockhardt UK Company Details

Table 97. Wockhardt UK Business Overview

Table 98. Wockhardt UK Oral Antidiabetic Agents Product

Table 99. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 100. Wockhardt UK Recent Developments

Table 101. Merck Company Details

Table 102. Merck Business Overview

Table 103. Merck Oral Antidiabetic Agents Product

Table 104. Merck Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 105. Merck Recent Developments

Table 106. Pfizer Company Details

Table 107. Pfizer Business Overview

Table 108. Pfizer Oral Antidiabetic Agents Product

Table 109. Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 110. Pfizer Recent Developments

Table 111. Cipla Company Details

Table 112. Cipla Business Overview

Table 113. Cipla Oral Antidiabetic Agents Product

Table 114. Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 115. Cipla Recent Developments

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Oral Antidiabetic Agents Market Share by Type: 2023 VS 2030

Figure 3. Sulfonylureas Features

Figure 4. Meglitinides Features

Figure 5. Biguanides Features

Figure 6. Thiazolidinediones Features

Figure 7. Alpha-glucosidase Inhibitors Features

Figure 8. Global Oral Antidiabetic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Oral Antidiabetic Agents Market Share by Application: 2023 VS 2030

Figure 10. Home Use Case Studies

Figure 11. Medical Institutions Case Studies

Figure 12. Others Case Studies

Figure 13. Oral Antidiabetic Agents Report Years Considered

Figure 14. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oral Antidiabetic Agents Market Share by Region: 2023 VS 2030

Figure 17. Global Oral Antidiabetic Agents Market Share by Players in 2023

Figure 18. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2023

Figure 20. North America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Oral Antidiabetic Agents Market Share by Type (2019-2030)

Figure 22. North America Oral Antidiabetic Agents Market Share by Application (2019-2030)

Figure 23. North America Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 24. United States Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Oral Antidiabetic Agents Market Share by Type (2019-2030)

Figure 28. Europe Oral Antidiabetic Agents Market Share by Application (2019-2030)

Figure 29. Europe Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 30. Germany Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Oral Antidiabetic Agents Market Share by Type (2019-2030)

Figure 38. China Oral Antidiabetic Agents Market Share by Application (2019-2030)

Figure 39. Asia Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Oral Antidiabetic Agents Market Share by Type (2019-2030)

Figure 41. Asia Oral Antidiabetic Agents Market Share by Application (2019-2030)

Figure 42. Asia Oral Antidiabetic Agents Market Share by Region (2019-2030)

Figure 43. Japan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 53. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 60. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 62. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 63. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 64. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 65. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 67. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 68. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Hypoglycemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antidiabetic OAD Treatment Market Research Report 2024

Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypoglycemic Drugs Market Insights Forecast to 2030

Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Oral Insulin Market Research Report 2025

Global Oral Hypoglycemic Agents and Insulin Injection Market Research Report 2025

Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Blood Glucose Regulators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Semaglutide Oral Drug Market Research Report 2024

Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral GLP 1 Agonist Market Research Report 2024

Global Gliclazide Market Research Report 2024

Global Type 2 Diabetes Medicines Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions